BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23040005)

  • 1. Sentinel lymph node involvement in ductal carcinoma in-situ of the breast: two different causes.
    Brouckaert O; Reynders A; Vanderstappen K; Smeets A; Hoeben A; Paridaens R; Christiaens MR; Floris G; Moerman P; Neven P
    Clin Breast Cancer; 2012 Oct; 12(5):378-81. PubMed ID: 23040005
    [No Abstract]   [Full Text] [Related]  

  • 2. Ductal carcinoma in situ with isolated tumor cells in the sentinel lymph node in a 17-year-old adolescent girl.
    Sato T; Muto I; Hasegawa M; Aono T; Sakai T; Oya T
    Breast Cancer; 2013 Jul; 20(3):271-4. PubMed ID: 20411367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 4. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema.
    Goldberg JI; Wiechmann LI; Riedel ER; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2010 Dec; 17(12):3278-86. PubMed ID: 20574774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    Hung WK; Ying M; Chan M; Mak KL; Chan LK
    Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
    Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
    Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
    Weaver DL
    Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
    Ge J; Yan B; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
    Miyake T; Shimazu K; Ohashi H; Taguchi T; Ueda S; Nakayama T; Kim SJ; Aozasa K; Tamaki Y; Noguchi S
    Am J Surg; 2011 Jul; 202(1):59-65. PubMed ID: 21741518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
    Ko BS; Lim WS; Kim HJ; Yu JH; Lee JW; Kwan SB; Lee YM; Son BH; Gong GY; Ahn SH
    Ann Surg Oncol; 2012 Jan; 19(1):212-6. PubMed ID: 21633867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
    Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
    Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast cancer from the viewpoint of the pathologist].
    Reiner A
    Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of frozen section in sentinel node biopsy in breast cancer.
    Gulec SA; Su J; O'Leary JP; Stolier A
    Am Surg; 2001 Jun; 67(6):529-32. PubMed ID: 11409799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sentinel lymph node biopsy in breast cancer: state of the art].
    Bauerfeind I; Himsl I; Kühn T; Untch M; Hepp H
    Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):84-91. PubMed ID: 15073437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 18. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
    Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the S classification of sentinel lymph node and microanatomic location of sentinel lymph node metastases to predict additional lymph node involvement and overall survival in breast cancer patients.
    Fink AM; Wondratsch H; Lass H; Janauer M; Sevelda P; Salzer H; Jurecka W; Ulrich W; Chott A; Steiner A
    Ann Surg Oncol; 2011 Jun; 18(6):1691-7. PubMed ID: 21249455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.